April 2009
Hepatic Impairment: The pharmacokinetics pletal kjope torsk of jotta geneeristen pletal cilostazol and its metabolites were similar in subjects with mild hepatic disease as compared kobe pletal c o d to healthy subjects.
Hepatic Impairment: The pharmacokinetics of cilostazol and its metabolites were similar in subjects with mild hepatic disease as compared to healthy subjects. PLETAL is contraindicated in patients with congestive heart failure of any severity. Therefore, dose of 50 mg twice daily should be considered when drugs that online receptpligtige pletal may increase the concentration of cilostazol also are being used.